Efficacy of Sequential BCMA CAR-T Cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in Transplant-eligible Newly Diagnosed Multiple Myeloma
NCT06913192
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
CAR-T
Sponsor
Xuzhou Medical University